Romosozumab for treating severe osteoporosis [ID3936] Proposed [GID-TA10828] Expected publication date: TBC Type Technology appraisal guidance Status Proposed
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer [ID3896] Proposed [GID-TA10812] Expected publication date: TBC Type Technology appraisal guidance Status Proposed